Drug intelligence / Profile preview

magnesium chloride + sodium acetate + sodium chloride + sodium gluconate + potassium chloride

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous, Topical
01

Overview

This drug is a balanced crystalloid intravenous solution composed of magnesium chloride, sodium acetate, sodium chloride, sodium gluconate, and potassium chloride. It is designed to mimic the electrolyte composition of human plasma and serves as a sterile, nonpyrogenic, isotonic replacement therapy. The solution is primarily indicated for the restoration of fluid and electrolyte balance in cases of dehydration, acute extracellular fluid loss, and electrolyte imbalance. The acetate and gluconate components act as alkalinizing agents by serving as metabolic precursors to bicarbonate, which helps in correcting metabolic acidosis. Formulations like Physiolyte are also utilized as irrigation solutions for general washing and rinsing during surgical procedures.

Brand names
Normosol-RPlasma-Lyte AIsolyte SPhysiolyte
Other names
Multiple Electrolytes Injection Type 1 USPBalanced Electrolyte SolutionMultiple Electrolytes Injection Type 1 USP pH 7.4Multiple Electrolytes Injection Type 1 USP pH 5.5

Beyond the preview

Go deeper on magnesium chloride + sodium acetate + sodium chloride + sodium gluconate + potassium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium chloride + sodium acetate + sodium chloride + sodium gluconate + potassium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call